Showing results (451-460 of 917) with videos related to
Sort By:
Pageof 92
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|May 24, 2001
Primary cardiac lipoblastomaM K Dishop, W N O'Connor, S Abraham, et al.Patient Education and Counseling|January 22, 2011
Health literacy and decision making styles for complex antithrombotic therapy among older multimorbid adultsAanand D Naik, Richard L Street, Diana Castillo, et al.Alimentary Pharmacology & Therapeutics|January 16, 2009
Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative studyJ M Cavazos, A D Naik, A Woofter, et al.The American Journal of Clinical Nutrition|September 1, 1981
Income matched black-white hemoglobin differences after correction for low transferrin saturationsS M Garn, A S Ryan, G M Owen, et al.Virology|August 1, 1990
Sequence and expression analysis of potential nonstructural proteins of 4.9, 4.8, 12.7, and 9.5 kDa encoded between the spike and membrane protein genes of the bovine coronavirusS Abraham, T E Kienzle, W E Lapps, et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1983
Biochemical changes in rat liver after 18.5 days of spaceflightS Abraham, C Y Lin, C M Volkmann, et al.The National Medical Journal of India|February 10, 2004
Symptoms related to the reproductive tract and mental health among women in rural southern IndiaJ Prasad, S Abraham, B Akila, et al.Lipids|November 1, 1983
Effect of specific dietary fatty acids on lipogenesis in the livers and mammary glands of lactating miceS Abraham, L A Hillyard, C Y Lin, et al.Vaccine|February 10, 2019
The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficienciesAntony R Parker, Miguel A Park, Stephen Harding, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1993
IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activityM Sykes, V S Abraham, M W Harty, et al.Pageof 92